FIELD: medicine.
SUBSTANCE: group of inventions relates to a compound selected from: 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
, 
or a pharmaceutically acceptable salt thereof, to use of said compounds for treating diseases selected from a group consisting of a chronic infectious disease, bacterial infection, parasitic infection, trauma, leprosy, tuberculosis, liver transplantation, cancer, fibrous diseases and their combination, and to a pharmaceutical composition containing the above compounds.
EFFECT: group of inventions provides producing the inhibitors of arginic activity, which can be used for treating the disease in a mammal, wherein the disease is characterized by either unusually high arginic activity, or unusually low levels of nitrogen oxide in the mammalian tissue.
3 cl, 14 dwg, 13 tbl, 173 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ARGINASE INHIBITORS AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2586219C2 |
| SUBSTITUTED IMIDAZOPYRIDINYL-AMINO-PYRIDINE COMPOUNDS, USEFUL FOR TREATMENT OF CANCER | 2010 |
|
RU2619463C2 |
| TRIAZOLOPYRIDINE JAK INHIBITOR COMPOUNDS AND METHODS | 2009 |
|
RU2561104C2 |
| ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
| NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITING NAMPT | 2011 |
|
RU2617424C2 |
| NOVEL DERIVATIVES OF BENZIMIDAZOLE AND THEIR USING AS MEDICAMENTS | 2002 |
|
RU2294326C2 |
| NEW DERIVATIVES BENZIMIDAZOLE AND IMIDAZOPYRIDINE AND THEIR APPLICATION AS MEDICINES | 2004 |
|
RU2330023C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| C-MET ANTAGONIST AND AMINOHETEROARYL COMBINATION FOR TREATING CANCER | 2009 |
|
RU2526171C2 |
| THERAPEUTIC ANTIDIABETIC AGENT | 2006 |
|
RU2438671C2 |
